Loading
Find Us on Facebook Follow Us on Twitter Bookmark & Share Subscribe to Feed
Wanna join our 6011 other users? | Register
Menu 

BIO SmartBrief

BiotechBlog

  • Biotechnology in Countries Starting with “I” – Part 13: Israel

    Biotechnology in Countries Starting with “I” – Part 13: Israel

    This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In all candor, I had no long-term intentions in February 2013 when I started this irregular s…
    - 14 days ago, 7 Jan 20, 1:16pm -
  • Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities

    Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities

    I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities at the 13th Annual Pharma Resource Planning & Portfolio Management in Philadelphia, PA on February 6th, 2020. You can…The post Upcoming Talk: Finding and Evaluating BioP…
    - 19 days ago, 2 Jan 20, 2:41pm -
  • The effect of patent expiration on sales of branded competitor drugs in a therapeutic class

    The effect of patent expiration on sales of branded competitor drugs in a therapeutic class

    DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and…The post The effect of patent expiration on sales of brand…
    - 36 days ago, 16 Dec 19, 2:55pm -
  • Customer Success: Will a generic version of a drug launch? And when?

    Customer Success: Will a generic version of a drug launch? And when?

    DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when…The post Customer S…
    - 40 days ago, 12 Dec 19, 1:22pm -
  • Customer Success: API and CDMO Business Development

    Customer Success: API and CDMO Business Development

    Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…The post Customer Success: API and CDMO Business…
    - 49 days ago, 3 Dec 19, 1:43pm -
  • Customer Success: API and CDMO Business Development

    Customer Success: API and CDMO Business Development

    Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…The post Customer Success: API and CDMO Business…
    - 49 days ago, 3 Dec 19, 1:43pm -
  • Customer Success: Law Firm Business Development

    Customer Success: Law Firm Business Development

    DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks…The post Customer Success: Law Firm Business Development ap…
    - 64 days ago, 18 Nov 19, 12:34pm -
  • Customer Success: Law Firm Business Development

    Customer Success: Law Firm Business Development

    DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks…The post Customer Success: Law Firm Business Development ap…
    - 64 days ago, 18 Nov 19, 12:34pm -
  • Mistakes to Be Avoided When Preparing a Drug Launch

    Mistakes to Be Avoided When Preparing a Drug Launch

    The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new…The post Mistakes to Be Avoided When Preparing a Drug Launch appeared first on DrugPatentWatch…
    - 82 days ago, 31 Oct 19, 10:27am -
  • Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

    Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

    This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…The post Development of the generic drug industry in the US…
    - 84 days ago, 29 Oct 19, 3:56pm -

BIOtechNow

Nature: Biotechnology

Phys.org: Biotechnology

Scientific American: Biotechnology

Janine Just, Inc.
Lux Smiles Dentistry
Recipe Test Nest
Stormseed
MyPopMuse

About PopMuse

A curated aggregation of musings from across the land and of different subject matters for the scanoholics.